Mirae Asset Global Investments
ARRY

Mirae Asset Global Investments’s Array Biopharma Inc ARRY Stock Holding History

Mirae Asset Global Investments’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-50,057
Closed -$2.32M – 1481
2019
Q2 		$2.32M Buy
50,057
+4,139
+9% +$116K 0.02% 659
2019
Q1 		$1.12M Buy
+45,918
New +$956K 0.01% 798

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Mirae Asset Global Investments's ARRY Position: Q3 2019 in Review

Mirae Asset Global Investments sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 50,057 shares — an estimated $2.32M sold.

Mirae Asset Global Investments first reported a position in ARRY in Q1 2019 and held it in 2 quarters. The position peaked at $2.32M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Mirae Asset Global Investments reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Mirae Asset Global Investments sold 50,057 Array Biopharma Inc shares in Q3 2019, an estimated $2.32M.
  • Mirae Asset Global Investments first reported a position in Array Biopharma Inc in Q1 2019 and held it in 2 quarters.
  • Mirae Asset Global Investments's Array Biopharma Inc position peaked at $2.32M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Mirae Asset Global Investments's 13F filing for Q3 2019, filed 12 Nov 2019.